Compare NAMS & AGX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | NAMS | AGX |
|---|---|---|
| Founded | 2019 | 1961 |
| Country | Netherlands | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Engineering & Construction |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.0B | 4.7B |
| IPO Year | N/A | N/A |
| Metric | NAMS | AGX |
|---|---|---|
| Price | $32.46 | $383.44 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 10 | 4 |
| Target Price | $46.40 | ★ $321.00 |
| AVG Volume (30 Days) | ★ 764.0K | 286.0K |
| Earning Date | 02-25-2026 | 12-04-2025 |
| Dividend Yield | N/A | ★ 0.52% |
| EPS Growth | N/A | ★ 76.74 |
| EPS | N/A | ★ 8.49 |
| Revenue | $35,243,000.00 | ★ $915,030,000.00 |
| Revenue This Year | N/A | $8.37 |
| Revenue Next Year | $10.46 | $28.04 |
| P/E Ratio | ★ N/A | $45.16 |
| Revenue Growth | 4.91 | ★ 13.49 |
| 52 Week Low | $14.06 | $101.02 |
| 52 Week High | $42.00 | $399.30 |
| Indicator | NAMS | AGX |
|---|---|---|
| Relative Strength Index (RSI) | 39.50 | 67.21 |
| Support Level | $30.97 | $308.58 |
| Resistance Level | $32.45 | $322.68 |
| Average True Range (ATR) | 1.64 | 18.76 |
| MACD | -0.24 | 6.31 |
| Stochastic Oscillator | 29.97 | 86.33 |
NewAmsterdam Pharma Co NV is a late-stage biopharmaceutical company with a mission to improve patient care in populations with metabolic diseases where currently approved therapies have not been adequate or well tolerated. Its product, obicetrapib, is a next-generation, oral, low-dose CETP inhibitor that is developed to potentially overcome the limitations of current LDL-C lowering treatments.
Argan Inc is a United States-based construction firm that conducts operations through its wholly-owned subsidiaries, GPS, APC, TRC, and SMC. Through GPS and APC it provides a full range of engineering, procurement, construction, commissioning, maintenance, project development and technical consulting services to the power generation market, including the renewable energy sector, for a wide range of customers, including independent power project owners, public utilities, power plant heavy equipment suppliers and other commercial firms with power requirements in the U.S., Ireland and the U.K. It operates in three segments: Power Services, Industrial Services, and Telecom Services, out of which Power Services derives the majority of revenue.